HighMark Wealth Management »

Crinetics Pharmaceuticals In shares owned by HighMark Wealth Management

Quarter-by-quarter ownership of Crinetics Pharmaceuticals In (CRNX) shares owned by HighMark Wealth Management from 13F filings

Historical chart of HighMark Wealth Management investment in Crinetics Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Crinetics Pharmaceuticals In held by HighMark Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crinetics Pharmaceuticals In by HighMark Wealth Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $806k 17k 46.81
2023-12-31 $151k 4.3k 35.58

More positions owned by HighMark Wealth Management

Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Eafe Value Etf (EFV)
Ishares Tr Russell 2000 Etf (IWM)
Ishares Tr Core S&p Scp Etf (IJR)
Ishares Tr Core S&p Us Vlu (IUSV)
Invesco Exch Traded Fd Tr Ii Dorsey Wrgt Smlc (DWAS)
Ishares Tr Core S&p Mcp Etf (IJH)
Wells Fargo & Company (WFC)
Performant Finl (PFMT)
Eli Lilly & Co. (LLY)
Ishares Tr S&p 500 Val Etf (IVE)
Microsoft Corporation (MSFT)
Us Bancorp Del Com New (USB)
Paragon 28 (FNA)
Tela Bio (TELA)

View all positions for HighMark Wealth Management

Top funds holding Crinetics Pharmaceuticals In

Vanguard Group
Point72 Asset Management
Wellington Management Company
T. Rowe Price Associates
Jennison Associates
Paradigm Biocapital Advisors
EcoR1 Capital
First Light Asset Management
OrbiMed Advisors
Perceptive Advisors
Cormorant Asset Management
Eventide Asset Management
Ikarian Capital
Lord, Abbett & Co
Dimensional Fund Advisors

View all funds holding Crinetics Pharmaceuticals In